In 1992 the European Community adopted Directive 92/27/EEC “On the labeling of medicinal products for human use and on package leaflets,” implementing the mandatory inclusion of full information leaflets written in understandable language in every medication package between January 1, 1994 and December 31, 1998. This article describes the features and historical motives of this new legislation. In addition, it reviews European research projects on the impact of written medication information.
Directive 92/27/EEC. In: O.J. 30.4.92; No L113:8–12. Brussels, Belgium; Commission of the European Community.
2.
GriffinJPSharpJR.Original pack dispensing. Br Med J.1987;294:724–725.
3.
RupfRE.Evaluation of patient-oriented drug information: Package leaflets as viewed by the patient and their impact on outpatients’ behaviour during treatment. Doctoral Thesis, University of Basel, Switzerland, 1991.
4.
Arzneimittelinformation für pflanzliche Heilmittel.Anforderungen an die Arzneimittelinformation für Patienten (Packungsbeilage für Pharmateutische Spezialitäten). Interkantonale Kontrollstelle IKS Monatsbericht1992;6:341–345.
5.
GriffinJP.Original manufacturers’ packs and patient information leaflets: a patient protection and right to know. J Roy Coll Phys London..
6.
GibbsSWatersWEGeorgeCF.The design of prescription information leaflets and feasibility of their use in general practice. Pharmaceut Med.1987;2:23–33.
7.
GibbsSWatersWEGeorgeCF.The benefits of prescription information leaflets (1). Br J Clin Pharmacol.1989;27:723–739.
8.
GibbsSWatersWEGeorgeCF.The benefits of prescription information leaflets (2). Br J Clin Pharmacol.1989;28:345–351.
9.
GibbsSWatersWEGeorgeCF.Communication information to patients about medicine. Prescription information leaflets: a national survey. J Roy Soc Med.1990;83:292–297.
10.
Association of British Pharmaceutical Industry.Information to patients on medicines. London; ABPI: 1987.
11.
Association of British Pharmaceutical Industry.Patient information: advice on the drafting of leaflets. London; ABPI: 1988.
12.
BogaertMVander SticheleRKaufmanJMLefebvreR (eds). Patient package inserts as a source of drug information.Amsterdam: Excerpta Medica; 1989.
13.
Vander SticheleRBogaertMG.Patient package inserts: the Belgian experience with a mandatory program. Drug Inf J.1989;23:673–677.
14.
Vander SticheleRHVan haechtCHBraemMDBogaertMG.Attitude of the public towards technical package inserts for medication information in Belgium. DICP. Ann Pharmacother.1991;25:1002–1006.
15.
BogaertMGVander SticheleRHDe PotterBVan haechtCHMVanden KerckhoveMPublic awareness of the introduction of patient package inserts in Belgium. In: Abstracts of the Vth World Conference on Clinical Pharmacology and Therapeutics. Yokohama, Japan: 1992; P-113–01.
16.
Van haechtCHMVander SticheleRBogaertMG.Package inserts for antihypertensive drugs: use by the patients and impact on adverse drug reactions. Eur J Clin Pharmacol.1990;39:551–554.
17.
Van haechtCHMVander SticheleRDe BackerGBogaertMG.Impact of patient package inserts on patients’ satisfaction, adverse drug reactions and risk perception: The case of NSAIDs for posttraumatic pain relief. Pat Educ Counsel.1991;17:205–215.
18.
Vander SticheleRHMestdaghJVan haechtCHMDe PotterBBogaertMG.Medication utilization and patient information in homes for the aged. Eur J Clin Pharmacol.1992;43:319–321.
19.
Vander SticheleRHDe PotterBVynckePBogaertMG.Attitude of physicians to patient package inserts for medication information in Belgium. In: Abstracts of the Annual Meeting of the Dutch and Belgian Society for Clinical Pharmacology. Utrecht: Dutch and Belgian Society for Clinical Pharmacology; 1993.
20.
JoossensL.Les notices de médicaments dans les douze pays de la Communauté Européenne. Rapport pour le Service Politique des Consommateurs de la Commission Européenne. CRIOC, Bruxelles, 1990.
21.
KlaukkaTAlankoE.Letter to the editor (reply to Kessler DA. Communicating with the patients about their medications N Engl J Med.1991;325: 1650–1652). N Engl J Med. 1991;327:132.
22.
Servizio di Informazione e di Educazione Sanitaria, Farmacie Comunali Italiane.What information for the patient? Large scale pilot study on experimental package inserts giving information on prescribed and over the counter drugs. Br Med J.1990;301:1261–1265.
23.
JoossensL.La lisibilité de l'étiquetage et des notices des médicaments. CRIOC, Bruxelles, 1993.
24.
KesslerDA.Communicating with the patients about their medications. N Engl J Med.1991;325:1650–1652.
25.
HamaRMasudaSNishimuraRNakagawaYNishibataYMoriKSakagamiAIzumiSA study on the effect of patients’ drug information leaflet. In: Abstracts of the Vth World Conference on Clinical Pharmacology and Therapeutics. Yokohama, Japan, 1992; O-35–05.
